New stem cell therapy freezes Multiple Sclerosis in its tracks

1 0

By Matthew Griffin Enhanced Humans and Biotech 1st March 2017

WHY THIS MATTERS IN BRIEF

Multiple Sclerosis is a debilitating disease that affects hundreds of thousands of people worldwide, but new therapies and treatments are bringing new hope to the people affected by it.

A new multiple sclerosis treatment that “resets” the human immune system has been found to “freeze” progression of the disease in nearly half of patients, according to a new announcement by scientists in London.

AI is helping design new drugs from scratch using text prompts and Zero Shot design

A study led by Imperial College London found that 46 per cent of patients who underwent the treatment did not suffer a worsening of their condition for five years, and now the treatment could give hope to the estimated 100,000 people in the UK who are affected by multiple sclerosis (MS), for which there is currently no cure.

The disease, which is caused by the immune system malfunctioning and mistakenly attacking nerve cells in the brain and spinal cord, leads to problems with movement, vision, balance and speech and often leaves people in wheelchairs. But now, the latest treatment which has been dubbed Autologous Hematopoietic Stem Cell Transplantation (AHSCT), which was given to patients with advanced forms of the disease who had failed to respond to other medications have given hundreds of thousands of sufferers new hope.

“We previously knew this treatment reboots or resets the immune system but we didn’t know how long the benefits lasted,” said Dr Paolo Muraro, the new study’s lead author, “in this study, which is the largest long term follow up study of its kind, we’ve shown we can ‘freeze’ a patient’s disease – and stop it from becoming worse, for up to five years.”

The researchers noted, however, that the nature of the treatment, which also involves aggressive chemotherapy to clear out, or eradicate, the patient’s own “faulty” bone marrow, carried “significant risks”.

New quantum scanners detect underground tunnels with uncanny accuracy

The chemotherapy deactivates their immune system for a short period of time, which can lead to greater risk of infection, and of the 281 patients who received AHSCT, eight died in the 100 days after treatment which works by destroying the immune cells responsible for attacking the nervous system.

The patients in the trials were given a drug that encouraged stem cells to move from the bone marrow and into the bloodstream, where they were removed from the body. High dose chemotherapy was then administered to kill all of the patient’s immune cells, before the patient’s own stem cells were put back into the body to “reset” the immune system.

While the results are encouraging it’s also clear that there’s still a lot of work left to do, but for many, the fact that scientists have been able to stop MS in its tracks is enough to give them hope that one day the disease might be beaten – no matter how far away that day is.

Matthew Griffin / About Author

Matthew Griffin, multi-award winning Futurist and named Futurist of the Year 2024, has been described as a "Walking encyclopaedia of the future" by NASA and a futurist polymath. One of the world's most renowned futurists and strategic foresight experts Matthew is the 15 times author of the blockbuster "Codex of the Future" series, and is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working across the next 50 years, XPotential University, the world's first free futures and foresight university, and the World Futures Forum which works with the United Nations to solve the worlds greatest challenges. Matthew is an in demand international keynote, acclaimed university lecturer and mentor, and host of the hit Fanatical Futurist podcast.

A rare talent in his past Matthew helped build and run several multi-billion dollar business units for Atos, Dell-EMC, and IBM, and his ability to identify, track, and explain the impacts of hundreds of emerging technologies and trends on global business, culture, and society has earned him a powerful reputation and a roster of clients that include royal households, world leaders, G7, G20, and G77+ governments, and many of the world's most respected brands including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi Group, Coca Cola, Dentons, Deloitte, Disney, Dow, EY, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, T-Mobile, UBS, VISA, and many others. He was also the only futurist invited to talk at the UN COP28 held in Dubai alongside world leaders.

Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.